Malgorzata Pietraszek has over 20 years of experience in CNS pharmacology acquired in both pharmaceutical industry and academic environments. Malgorzata holds a PhD from the Institute of Pharmacology Polish Academy of Sciences (PAS) in Cracow, Poland and MSc from Jagiellonian University, Cracow, Poland. Between 1993 and 2007, Malgorzata conducted research in the therapeutic areas of schizophrenia and Parkinson’s disease at the Institute of Pharmacology PAS in Cracow. During this time, she maintained active collaborations with other departments of the Institute and external partners from academia and pharmaceutical industry that resulted in numerous publications and meeting presentations. In 2007, Malgorzata joined Merz Pharmaceuticals (Germany) as a scientific expert involved in preclinical drug research and development program in different CNS indications and stayed in this role till 2014. She implemented many in vivo models, trained postdocs and technicians and organized internal workshops to accelerate drug research and development in the therapeutic areas of schizophrenia and neurodegenerative disorders. She also supported clinical development in the therapeutic areas of CNS disorders. Malgorzata established and managed collaborations with key opinion experts from academia as well as with many Contract Research Organizations. Additionally, she was involved in in vivo preclinical data quality assessment.